Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
43 Leser
Artikel bewerten:
(0)

Europe Soft Tissue Reinforcement and Regeneration Market Report 2018 - Unit Sales, ASPs, Market Value & Growth Trends

DUBLIN, Feb. 2, 2018 /PRNewswire/ --

The "Europe Market Report Suite for Soft Tissue Reinforcement and Regeneration 2018 - MedSuite" report has been added to ResearchAndMarkets.com's offering.

General Report Contents

Research and Markets Logo
  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

The European market for soft tissue reinforcement and regeneration includes graft devices that are designed to reinforce and regenerate soft tissues. Soft tissues are defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, nerves and blood vessels. Collagen, the most abundant protein in mammals, is one of the characteristic elements inside the extracellular matrix of soft tissue and, as such, plays a critical role in soft tissue repair.

Because soft tissue essentially makes up the majority of a person, and there are countless medical conditions associated with soft tissue problems, a select group of large markets related to soft tissue repair will be covered in this report, including breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration. These indications were selected because they feature the use of synthetic mesh and biological matrices to reinforce and regenerate deficient areas.

There are three primary classes of soft tissue reinforcement and regeneration devices: allografts, xenografts, and alloplasts.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. European Soft Tissue Reinforcement and Regeneration Market Overview
2.1 Introduction
2.2 Currency Exchange Rate
2.3 Market Overview
2.4 Trend Analysis By Segment
2.5 Drivers and Limiters
2.5.1 Market Drivers
2.5.2 Market Limiters
2.6 Competitive Market Share Analysis

3. Country Profiles
3.1 Introduction
3.1.1.1 Population
3.1.1.2 Median Age
3.1.1.3 GDP Per Capita
3.1.1.4 Price Index
3.2 Germany
3.3 France
3.4 United Kingdom
3.5 Italy
3.6 Spain
3.7 Benelux
3.8 Scandinavia
3.9 Austria
3.10 Switzerland
3.11 Portugal

4. Procedure Numbers
4.1 Introduction
4.2 Procedure Numbers
4.3 Breast Reconstruction
4.3.1 Breast Cancer Diagnoses
4.3.2 Mastectomies
4.3.3 Breast Reconstruction Procedures Performed
4.3.3.1 Tissues Expander/Implant-Based Breast Reconstruction Procedures Performed
4.3.3.2 Autologous Breast Reconstruction Procedures Performed
4.3.3.2.1 Flap Varieties
4.3.3.2.2 Flap Techniques
4.4 Hernia Repair
4.4.1 Total Hernia Repair Procedure Numbers
4.4.1.1 Ventral Hernia Repair Procedure Numbers
4.4.1.2 Inguinal Hernia Repair Procedure Numbers
4.5 Dural Repair
4.6 Vaginal Slings
4.7 Skin Repair
4.8 Sports Medicine and Tendon Reinforcement
4.9 Dental Soft Tissue Regeneration

5. Breast Reconstruction Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis and Forecast
5.3.1 Total Breast Reconstruction Market
5.3.2 Biologic Breast Reconstruction Market
5.3.3 Total Synthetic Breast Reconstruction Market
5.3.3.1 Resorbable Synthetic Breast Reconstruction Market
5.3.3.2 Non-Resorbable Synthetic Breast Reconstruction Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
5.5.1 Leading Competitors By Segment
5.5.2 Biologic Breast Reconstruction Market
5.5.3 Synthetic Breast Reconstruction Market

6. Hernia Repair Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Total Ventral Hernia Repair Market
6.3.1.1 Ventral Biologic Hernia Repair Market
6.3.1.2 Total Ventral Synthetic Hernia Repair Market
6.3.1.2.1 Composite Ventral Synthetic Hernia Repair Market
6.3.1.2.2 Non-Coated Ventral Synthetic Hernia Repair Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis
6.5.1 Leading Competitors By Segment
6.5.2 Biologic Hernia Repair Market
6.5.3 Synthetic Hernia Repair Market

7. Dural Repair Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Dural Repair Market
7.3.2 Biologic Dural Repair Market
7.3.3 Synthetic Dural Repair Market
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis
7.5.1 Leading Competitors By Segment
7.5.2 Biologic Dural Repair Market
7.5.3 Synthetic Dural Repair Market

8. Vaginal Sling Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Total Vaginal Sling Market
8.3.2 Biologic Vaginal Sling Market
8.3.3 Synthetic Vaginal Sling Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

9. Skin Repair Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Skin Substitute Market
9.3.2 Collagen Dressing Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis
9.5.1 Leading Competitors By Segment
9.5.2 Skin Substitute Market
9.5.3 Collagen Dressing Market

10. Sports Medicine and Tendon Reinforcement Market
10.1 Introduction
10.2 Market Analysis and Forecast
10.2.1 Biologic Rotator Cuff Reinforcement Market
10.3 Drivers and Limiters
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 Competitive Market Share Analysis

11. Dental Soft Tissue Regeneration Market
11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 Total Dental Soft Tissue Regeneration Market
11.3.2 Allograft Dental Soft Tissue Regeneration Market
11.3.3 Xenograft Dental Soft Tissue Regeneration Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Companies Mentioned

  • Covidien
  • Ethicon
  • C.R. Bard
  • Integra LifeSciences
  • LifeCell
  • Aesculap/B. Braun
  • Systagenix
  • Medskin
  • Cook Medical
  • American Medical Systems
  • Boston Scientific

For more information about this report visit https://www.researchandmarkets.com/research/rwtfst/europe_market?w=5

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2018 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.